CD8A and neoplasm: Tumor infiltrating lymphocytes (TIL) have prognostic value in a variety of cancers [3,4,5,6,7]; with a survival advantage associated with the presence of tumor infiltrating CD3+ T cells and cytotoxic CD8+ T cells [5].